Dunn Edmund bought GLUE
January 2, 2024 · Form 4 insider transaction
Dunn Edmund bought 35,900 shares of Monte Rosa Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
35,900
Price
$0.00
Total value
N/A
InsiderDunn Edmund
RoleOfficer
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJanuary 2, 2024
Filing dateJanuary 4, 2024
Shares owned after35,900
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
25% of this option shall vest and become exercisable on January 1, 2025, with the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.